# Gabapentin and Donepezil Combination on Experimental Human Pain Models

> **NCT01485185** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 48 (actual)

## Conditions studied

- Pain, Neuropathic

## Interventions

- **DRUG:** Gabapentin lower dose
- **DRUG:** Donepezil
- **OTHER:** Placebo (Dop)
- **OTHER:** Placebo (Gaba)
- **DRUG:** Gabapentin higher dose

## Key facts

- **NCT ID:** NCT01485185
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10-11
- **Primary completion:** 2012-07-03
- **Final completion:** 2012-07-03
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01485185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01485185, "Gabapentin and Donepezil Combination on Experimental Human Pain Models". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01485185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*